As per the terms of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to Viralliance to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient.
As per the terms of the patent license agreement, ABL has granted a non-exclusive, royalty-bearing license to Viralliance to use the ABL patent portfolio for guiding and ranking the selection of a therapeutic regimen for a given patient.